Austin Larson

2.5k total citations
36 papers, 329 citations indexed

About

Austin Larson is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Austin Larson has authored 36 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Genetics and 8 papers in Clinical Biochemistry. Recurrent topics in Austin Larson's work include Mitochondrial Function and Pathology (9 papers), Metabolism and Genetic Disorders (8 papers) and Genomics and Rare Diseases (6 papers). Austin Larson is often cited by papers focused on Mitochondrial Function and Pathology (9 papers), Metabolism and Genetic Disorders (8 papers) and Genomics and Rare Diseases (6 papers). Austin Larson collaborates with scholars based in United States, Australia and Canada. Austin Larson's co-authors include Shireen Banerji, Jon Kaufman, Penelope E. Bonnen, Natalie Nokoff, Ellen Roy Elias, Johan L.K. Van Hove, David E. Mandelbaum, Jasleen Singh, Peter R. Baker and Johan Van Hove and has published in prestigious journals such as Human Molecular Genetics, Genetics in Medicine and Molecular Genetics and Metabolism.

In The Last Decade

Austin Larson

32 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Austin Larson United States 11 179 80 69 35 34 36 329
Khalid Al‐Thihli Oman 13 219 1.2× 116 1.4× 135 2.0× 58 1.7× 66 1.9× 50 456
Carlos E. Speck‐Martins Brazil 11 137 0.8× 58 0.7× 66 1.0× 48 1.4× 25 0.7× 23 314
Heiko Brennenstuhl Germany 11 180 1.0× 74 0.9× 99 1.4× 16 0.5× 30 0.9× 25 315
Suzanne D. DeBrosse United States 12 246 1.4× 115 1.4× 182 2.6× 22 0.6× 55 1.6× 17 422
Yoichi Wada Japan 13 209 1.2× 39 0.5× 113 1.6× 41 1.2× 43 1.3× 27 372
Natsuko Arai‐Ichinoi Japan 10 160 0.9× 94 1.2× 107 1.6× 58 1.7× 36 1.1× 18 398
Christine Makowski Germany 10 229 1.3× 51 0.6× 143 2.1× 94 2.7× 51 1.5× 18 480
Emma Glamuzina New Zealand 11 148 0.8× 62 0.8× 149 2.2× 61 1.7× 68 2.0× 30 323
Anna Marcé‐Grau Spain 10 139 0.8× 48 0.6× 52 0.8× 8 0.2× 20 0.6× 19 284
Keiko Ishigaki Japan 13 252 1.4× 41 0.5× 46 0.7× 17 0.5× 110 3.2× 58 476

Countries citing papers authored by Austin Larson

Since Specialization
Citations

This map shows the geographic impact of Austin Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Austin Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Austin Larson more than expected).

Fields of papers citing papers by Austin Larson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Austin Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Austin Larson. The network helps show where Austin Larson may publish in the future.

Co-authorship network of co-authors of Austin Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Austin Larson. A scholar is included among the top collaborators of Austin Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Austin Larson. Austin Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazza, Gina L., Andrew C. Edmondson, Fernando Scaglia, et al.. (2025). Goal attainment in PMM2-CDG: A new approach measuring meaningful clinical outcomes. Molecular Genetics and Metabolism. 145(1). 109087–109087.
2.
Larson, Austin, Naomi Meeks, Marisa W. Friederich, et al.. (2024). An integrated multi-omics approach allowed ultra-rapid diagnosis of a deep intronic pathogenic variant in PDHX and precision treatment in a neonate critically ill with lactic acidosis. Mitochondrion. 79. 101973–101973. 2 indexed citations
3.
Hove, Johan L.K. Van, Marisa W. Friederich, Daniella H. Hock, et al.. (2024). ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis. Mitochondrion. 78. 101905–101905. 3 indexed citations
4.
Zemet, Roni, Andrew C. Edmondson, Justin H. Berger, et al.. (2024). Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation. Molecular Genetics and Metabolism. 142(4). 108513–108513. 4 indexed citations
5.
DeBarber, Andrea E., Ernst J. Schaefer, Jenny Do, et al.. (2024). Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols. Journal of clinical lipidology. 18(3). e465–e476. 1 indexed citations
6.
Steiner, Robert D., et al.. (2023). Living with Cerebrotendinous Xanthomatosis: Patient, Caregiver, and Expert Perspectives. Advances in Therapy. 41(2). 467–475.
7.
Bayat, Allan, Zhenjiang Liu, Sheng Luo, et al.. (2023). A new neurodevelopmental disorder linked to heterozygous variants in UNC79. Genetics in Medicine. 25(9). 100894–100894. 13 indexed citations
8.
Chung, Hyung-Lok, Patrick Rump, Jawid M. Fatih, et al.. (2022). De novo variants in EMC1 lead to neurodevelopmental delay and cerebellar degeneration and affect glial function in Drosophila. Human Molecular Genetics. 31(19). 3231–3244. 13 indexed citations
9.
Baker, Peter R., Janet A. Thomas, Heather E. Skillman, et al.. (2021). REVIEW: Practical strategies to maintain anabolism by intravenous nutritional management in children with inborn metabolic diseases. Molecular Genetics and Metabolism. 133(3). 231–241. 6 indexed citations
10.
Larson, Austin, David M. Mirsky, Yue Wang, et al.. (2020). The mitochondrial DNA variant m.9032T > C in MT-ATP6 encoding p.(Leu169Pro) causes a complex mitochondrial neurological syndrome. Mitochondrion. 55. 8–13. 4 indexed citations
11.
Friederich, Marisa W., Ting Chen, Austin Larson, et al.. (2020). A novel acceptor stem variant in mitochondrial tRNATyr impairs mitochondrial translation and is associated with a severe phenotype. Molecular Genetics and Metabolism. 131(4). 398–404. 2 indexed citations
12.
Larson, Austin, Shanti Balasubramaniam, John Christodoulou, et al.. (2018). Biochemical signatures mimicking multiple carboxylase deficiency in children with mutations in MT-ATP6. Mitochondrion. 44. 58–64. 17 indexed citations
13.
Starr, Michelle C., Irene J. Chang, Laura S. Finn, et al.. (2018). COQ2 nephropathy: a treatable cause of nephrotic syndrome in children. Pediatric Nephrology. 33(7). 1257–1261. 26 indexed citations
14.
Larson, Austin, Peter R. Baker, Miroslav P. Milev, et al.. (2018). TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy. Skeletal Muscle. 8(1). 17–17. 41 indexed citations
15.
Emrick, Lisa, Jill A. Rosenfeld, Seema R. Lalani, et al.. (2018). Microdeletions excluding YWHAE and PAFAH1B1 cause a unique leukoencephalopathy: further delineation of the 17p13.3 microdeletion spectrum. Genetics in Medicine. 21(7). 1652–1656. 11 indexed citations
16.
Larson, Austin, Marisa W. Friederich, Michael A. Swanson, et al.. (2017). New insights into the phenotype of FARS2 deficiency. Molecular Genetics and Metabolism. 122(4). 172–181. 35 indexed citations
17.
Larson, Austin, James D. Weisfeld‐Adams, Tim A. Benke, & Penelope E. Bonnen. (2016). Cerebrotendinous Xanthomatosis Presenting with Infantile Spasms and Intellectual Disability. JIMD Reports. 35. 1–5. 10 indexed citations
18.
Larson, Austin, Natalie Nokoff, & Naomi Meeks. (2015). Genetic causes of pituitary hormone deficiencies.. PubMed. 19(104). 175–83. 8 indexed citations
19.
Larson, Austin, et al.. (2013). Seizures and Methemoglobinemia in an Infant After Excessive EMLA Application. Pediatric Emergency Care. 29(3). 377–379. 27 indexed citations
20.
Larson, Austin & David E. Mandelbaum. (2012). Association of Head Circumference and Shoulder Dystocia in Macrosomic Neonates. Maternal and Child Health Journal. 17(3). 501–504. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Khalid Al‐Thihli Breakdown of academic impact, for papers by Carlos E. Speck‐Martins Breakdown of academic impact, for papers by Heiko Brennenstuhl Breakdown of academic impact, for papers by Suzanne D. DeBrosse Breakdown of academic impact, for papers by Yoichi Wada Breakdown of academic impact, for papers by Natsuko Arai‐Ichinoi Breakdown of academic impact, for papers by Christine Makowski Breakdown of academic impact, for papers by Emma Glamuzina Breakdown of academic impact, for papers by Anna Marcé‐Grau Breakdown of academic impact, for papers by Keiko Ishigaki
Rankless by CCL
2026